If you know anything about me, you know I’m concerned about the AI boom. However, there is one big, obvious, already-starting ...

The Office of the National Coordinator for Health IT has entered into a cooperative agreement with Integrating the Health Enterprise USA to jointly advance interoperability goals. Together, ONC and ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

IHE invests in U.S. pharmaceutical stocks. Based on consensus forward earnings growth estimates, IHE looks undervalued. A high IRR is possible, especially if the portfolio's long-term earnings ...

The first strong outlook factor for IHE is its inclusion of Eli Lilly at almost 27% weight. The pharmaceutical company has seen tremendous growth due to Mounjaro, approved by the FDA in 2022, and ...

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, ...

iShares U.S. Pharmaceuticals ETF (IHE) has 46.8% of its $1.1B portfolio concentrated in Johnson & Johnson (JNJ), up 14% year-to-date on strong DARZALEX sales of $3.90B, and Eli Lilly (LLY), down 15% ...